Based on the observations indicating that the transmembrane receptor, tissue factor (TF) for coagulation factor VIIa is aberrantly and abundantly expressed on many cancer cells, a new delivery system has also been developed to specifically target the TF-expressing cancer cells with the curcumin analog, EF24 [209]. This evidence concerns the gene TF and cancer.